AVTX filings
Corporate insider profile
Jennifer Riley Filing Activity
Latest reported as Chief Strategy Officer of Avalo Therapeutics, Inc. (AVTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$52,012.25
- Latest transaction
- Aug 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
